Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioAtla (BCAB) Net Cash Flow (2020 - 2025)

BioAtla (BCAB) has 6 years of Net Cash Flow data on record, last reported at -$9.9 million in Q3 2025.

  • For Q3 2025, Net Cash Flow fell 92.13% year-over-year to -$9.9 million; the TTM value through Sep 2025 reached -$48.2 million, up 43.14%, while the annual FY2024 figure was -$62.4 million, 40.0% up from the prior year.
  • Net Cash Flow reached -$9.9 million in Q3 2025 per BCAB's latest filing, up from -$14.2 million in the prior quarter.
  • Across five years, Net Cash Flow topped out at $62.3 million in Q3 2021 and bottomed at -$30.8 million in Q1 2024.
  • Average Net Cash Flow over 5 years is -$12.1 million, with a median of -$17.4 million recorded in 2021.
  • Peak YoY movement for Net Cash Flow: tumbled 7206.45% in 2021, then soared 249.87% in 2022.
  • A 5-year view of Net Cash Flow shows it stood at -$24.9 million in 2021, then skyrocketed by 249.87% to $37.4 million in 2022, then plummeted by 179.74% to -$29.8 million in 2023, then skyrocketed by 74.94% to -$7.5 million in 2024, then tumbled by 32.36% to -$9.9 million in 2025.
  • Per Business Quant database, its latest 3 readings for Net Cash Flow were -$9.9 million in Q3 2025, -$14.2 million in Q2 2025, and -$16.7 million in Q1 2025.